1. Home
  2. NTNX vs QGEN Comparison

NTNX vs QGEN Comparison

Compare NTNX & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nutanix Inc.

NTNX

Nutanix Inc.

HOLD

Current Price

$39.42

Market Cap

10.9B

Sector

Technology

ML Signal

HOLD

Logo Qiagen N.V.

QGEN

Qiagen N.V.

HOLD

Current Price

$41.28

Market Cap

10.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTNX
QGEN
Founded
2009
1986
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.9B
10.2B
IPO Year
2015
1998

Fundamental Metrics

Financial Performance
Metric
NTNX
QGEN
Price
$39.42
$41.28
Analyst Decision
Buy
Buy
Analyst Count
18
9
Target Price
$64.06
$51.30
AVG Volume (30 Days)
2.9M
1.7M
Earning Date
05-27-2026
05-06-2026
Dividend Yield
N/A
6.01%
EPS Growth
227.45
N/A
EPS
0.57
N/A
Revenue
$2,537,927,000.00
N/A
Revenue This Year
$13.60
$8.18
Revenue Next Year
$13.18
$5.71
P/E Ratio
$69.20
$24.01
Revenue Growth
18.11
N/A
52 Week Low
$35.39
$38.80
52 Week High
$83.36
$57.82

Technical Indicators

Market Signals
Indicator
NTNX
QGEN
Relative Strength Index (RSI) 49.90 45.28
Support Level $37.87 $38.80
Resistance Level $42.50 $48.80
Average True Range (ATR) 1.80 0.83
MACD 0.15 0.44
Stochastic Oscillator 51.54 84.09

Price Performance

Historical Comparison
NTNX
QGEN

About NTNX Nutanix Inc.

Nutanix Inc is engaged in cloud software, offering organizations a single platform for running applications and managing data anywhere. Its Nutanix Cloud Platform is designed to enable organizations to build a hybrid multicloud infrastructure, providing a consistent cloud operating model with a single platform for running applications and managing data in core data centers, at the edge, and in public clouds, all while supporting a variety of hypervisors and container platforms. The company operates a single operating and reportable segment based on a subscription business model. It conducts business in the United States, Europe, the Middle East and Africa, Asia Pacific, and other Americas, with key revenue generated from the United States.

About QGEN Qiagen N.V.

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).

Share on Social Networks: